Clinical trials: sponsored by Jonsson Comprehensive Cancer Center
Cancer, Inflammation
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.
- Trial name
- NCT01180907
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Jonsson Comprehensive Cancer Center